Synlogic, Inc. (SYBX) stock
SYBXOTCPharmaceutical PreparationsFiscal year ends December 31
$1.07+0.07 (+7.00%)
Close on Oct 19, 2026Market cap $13.29MP/E –Yield –
Synlogic cash
Cash and short-term investments held at the end of each period.
Synlogic's cash was $11.60M at Sep 30, 2026. For fiscal 2025 it was $14.70M, down 22.2% from the year before. Over ten years it grew 9.0% a year on average. The highest annual figure on record is $136.60M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.70M | -22.2% |
| FY2024 | Dec 31, 2024 | $18.90M | +39622541.5% |
| FY2023 | Dec 31, 2023 | $48 | -100.0% |
| FY2022 | Dec 31, 2022 | $77.60M | -43.2% |
| FY2021 | Dec 31, 2021 | $136.60M | +36.1% |
| FY2020 | Dec 31, 2020 | $100.40M | -16.1% |
| FY2019 | Dec 31, 2019 | $119.60M | -2.5% |
| FY2018 | Dec 31, 2018 | $122.70M | +41.0% |
| FY2017 | Dec 31, 2017 | $87.00M | +494.4% |
| FY2016 | Dec 31, 2016 | $14.64M | +135.0% |
| FY2015 | Dec 31, 2015 | $6.23M | -33.2% |
| FY2014 | Dec 31, 2014 | $9.32M | -59.8% |
| FY2013 | Dec 31, 2013 | $23.18M | +74.7% |
| FY2012 | Dec 31, 2012 | $13.27M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $11.60M | -25.6% |
| Q2 FY2026 | Jun 30, 2026 | $13.20M | -22.4% |
| Q1 FY2026 | Mar 31, 2026 | $14.10M | -18.5% |
| Q4 FY2025 | Dec 31, 2025 | $14.70M | -22.2% |
| Q3 FY2025 | Sep 30, 2025 | $15.60M | -19.6% |
| Q2 FY2025 | Jun 30, 2025 | $17.00M | -15.0% |
| Q1 FY2025 | Mar 31, 2025 | $17.30M | -46.4% |
| Q4 FY2024 | Dec 31, 2024 | $18.90M | +39622541.5% |
| Q3 FY2024 | Sep 30, 2024 | $19.40M | -41.9% |
| Q2 FY2024 | Jun 30, 2024 | $20.00M | -56.8% |
| Q1 FY2024 | Mar 31, 2024 | $32.30M | -43.7% |
| Q4 FY2023 | Dec 31, 2023 | $48 | -100.0% |
| Q3 FY2023 | Sep 30, 2023 | $33.40M | -63.6% |
| Q2 FY2023 | Jun 30, 2023 | $46.30M | -56.6% |
| Q1 FY2023 | Mar 31, 2023 | $57.40M | -52.4% |
| Q4 FY2022 | Dec 31, 2022 | $77.60M | -43.2% |
| Q3 FY2022 | Sep 30, 2022 | $91.70M | -38.9% |
| Q2 FY2022 | Jun 30, 2022 | $106.80M | -7.5% |
| Q1 FY2022 | Mar 31, 2022 | $120.50M | +27.6% |
| Q4 FY2021 | Dec 31, 2021 | $136.60M | +36.1% |
| Q3 FY2021 | Sep 30, 2021 | $150.10M | +47.2% |
| Q2 FY2021 | Jun 30, 2021 | $115.50M | +5.9% |
| Q1 FY2021 | Mar 31, 2021 | $94.40M | -17.3% |
| Q4 FY2020 | Dec 31, 2020 | $100.40M | -16.1% |
| Q3 FY2020 | Sep 30, 2020 | $102.00M | -15.2% |
| Q2 FY2020 | Jun 30, 2020 | $109.10M | -15.4% |
| Q1 FY2020 | Mar 31, 2020 | $114.20M | +4.0% |
| Q4 FY2019 | Dec 31, 2019 | $119.60M | -2.5% |
| Q3 FY2019 | Sep 30, 2019 | $120.30M | -9.3% |
| Q2 FY2019 | Jun 30, 2019 | $129.00M | -9.9% |
| Q1 FY2019 | Mar 31, 2019 | $109.80M | -12.7% |
| Q4 FY2018 | Dec 31, 2018 | $122.70M | +41.0% |
| Q3 FY2018 | Sep 30, 2018 | $132.60M | +67.5% |
| Q2 FY2018 | Jun 30, 2018 | $143.20M | +840.9% |
| Q1 FY2018 | Mar 31, 2018 | $125.80M | +267.9% |
| Q4 FY2017 | Dec 31, 2017 | $87.00M | +494.4% |
| Q3 FY2017 | Sep 30, 2017 | $79.18M | – |
| Q2 FY2017 | Jun 30, 2017 | $15.22M | – |
| Q1 FY2017 | Mar 31, 2017 | $34.20M | – |
| Q4 FY2016 | Dec 31, 2016 | $14.64M | – |
See a number that looks wrong?